Cargando…

MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor

The aim of this study was to assess the potential implication of microRNA on tuberous sclerosis (TSC) pathogenesis by performing microRNA profiling on cell lines silencing TSC1 or TSC2 genes using qPCR panels, before and after incubation with rapamycin. Significant differences in expression were obs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pawlik, Bartłomiej, Grabia, Szymon, Smyczyńska, Urszula, Fendler, Wojciech, Dróżdż, Izabela, Liszewska, Ewa, Jaworski, Jacek, Kotulska, Katarzyna, Jóźwiak, Sergiusz, Młynarski, Wojciech, Trelińska, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694073/ https://www.ncbi.nlm.nih.gov/pubmed/36430972 http://dx.doi.org/10.3390/ijms232214493

Ejemplares similares

mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

New Insights into Red Blood Cell Microcytosis upon mTOR Inhibitor Administration
por: Jakubowska, Justyna, et al.
Publicado: (2021)

Abnormal serum microRNA profiles in tuberous sclerosis are normalized during treatment with everolimus: possible clinical implications
por: Trelinska, Joanna, et al.
Publicado: (2016)

NormiRazor: tool applying GPU-accelerated computing for determination of internal references in microRNA transcription studies
por: Grabia, Szymon, et al.
Publicado: (2020)

Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis – Final Results From the EMINENTS Study
por: Bobeff, Katarzyna, et al.
Publicado: (2021)

mTOR controls endoplasmic reticulum–Golgi apparatus trafficking of VSVg in specific cell types
por: Koscielny, Alicja, et al.
Publicado: (2021)

A systemic approach to screening high-throughput RT-qPCR data for a suitable set of reference circulating miRNAs
por: Pagacz, Konrad, et al.
Publicado: (2020)

Prediction of Radiation-Induced Hypothyroidism Using Radiomic Data Analysis Does Not Show Superiority over Standard Normal Tissue Complication Models
por: Smyczynska, Urszula, et al.
Publicado: (2021)

Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Proteomic and Transcriptomic Landscapes of Alström and Bardet–Biedl Syndromes
por: Smyczynska, Urszula, et al.
Publicado: (2022)

Adaptor Complex 2 Controls Dendrite Morphology via mTOR-Dependent Expression of GluA2
por: Koscielny, Alicja, et al.
Publicado: (2017)

Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?
por: Habib, Samy L, et al.
Publicado: (2016)

GSK3β Controls mTOR and Prosurvival Signaling in Neurons
por: Urbanska, Malgorzata, et al.
Publicado: (2017)

mTOR kinase is needed for the development and stabilization of dendritic arbors in newly born olfactory bulb neurons
por: Skalecka, Agnieszka, et al.
Publicado: (2016)

Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer
por: Mrozek, Evelyn M., et al.
Publicado: (2021)

The TSC-mTOR pathway regulates macrophage polarization
por: Byles, Vanessa, et al.
Publicado: (2013)

Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2
por: Kwiatkowski, David J, et al.
Publicado: (2015)

Treatment of Cardiac Rhabdomyomas with mTOR Inhibitors in Children with Tuberous Sclerosis Complex—A Systematic Review
por: Sugalska, Monika, et al.
Publicado: (2021)

Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway
por: Presneau, N, et al.
Publicado: (2009)

Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated
por: Cabrera-López, Cristina, et al.
Publicado: (2015)

Methylation of Hypothalamic Tsc1-mTOR Signaling in Regulation of Obesity and Obesity Resistance
por: Wang, Yanli, et al.
Publicado: (2020)

Seizure reduction in TSC2‐mutant mouse model by an mTOR catalytic inhibitor
por: Dhamne, Sameer C., et al.
Publicado: (2023)

Successful combination treatment of a bifocal secretory germinoma with brain stem compression in a 17-year-old girl
por: Chalubinska-Fendler, Justyna, et al.
Publicado: (2016)

Safety of Sirolimus in Patients with Tuberous Sclerosis Complex under Two Years of Age—A Bicenter Retrospective Study
por: Śmiałek, Dominika, et al.
Publicado: (2023)

Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study
por: Chalubinska-Fendler, Justyna, et al.
Publicado: (2015)

Carboxy Terminal Tail of Polycystin-1 Regulates Localization of TSC2 to Repress mTOR
por: Dere, Ruhee, et al.
Publicado: (2010)

Effects of antiepileptic drugs in a new TSC/mTOR‐dependent epilepsy mouse model
por: Koene, Linda M. C., et al.
Publicado: (2019)

Association of circulating miRNAS in patients with Alstrőm and Bardet-Biedl syndromes with clinical course parameters
por: Zmyslowska, Agnieszka, et al.
Publicado: (2022)

The mTOR pathway genes mTOR, Rheb, Depdc5, Pten, and Tsc1 have convergent and divergent impacts on cortical neuron development and function
por: Nguyen, Lena H., et al.
Publicado: (2023)

Treatment effect of mTOR-inhibition on tissue composition of renal angiomyolipomas in tuberous sclerosis complex (TSC)
por: Brakemeier, Susanne, et al.
Publicado: (2017)

TSC1 and DEPDC5 regulate HIV-1 latency through the mTOR signaling pathway
por: Jin, Shan, et al.
Publicado: (2018)

Switching to Sulphonylureas in Children With iDEND Syndrome Caused by KCNJ11 Mutations Results in Improved Cerebellar Perfusion
por: Fendler, Wojciech, et al.
Publicado: (2013)

Matricellular proteins of the Cyr61/CTGF/NOV (CCN) family and the nervous system
por: Malik, Anna R., et al.
Publicado: (2015)

Radiation-induced circulating microRNAs linked to echocardiography parameters after radiotherapy
por: Chałubińska-Fendler, Justyna, et al.
Publicado: (2023)

The Stricter the Better? The Relationship between Targeted HbA(1c) Values and Metabolic Control of Pediatric Type 1 Diabetes Mellitus
por: Braun, Marcin, et al.
Publicado: (2016)

Impact of mTOR expression on clinical outcome in paediatric patients with B-cell acute lymphoblastic leukaemia – preliminary report
por: Ulińska, Edyta, et al.
Publicado: (2016)

Neutrophil Elastase Defects in Congenital Neutropenia
por: Rydzynska, Zuzanna, et al.
Publicado: (2021)

GlyCulator 3.0: A Fast, Easy-to-Use Analytical Tool for CGM Data Analysis, Aggregation, Center Benchmarking, and Data Sharing
por: Chrzanowski, Jędrzej, et al.
Publicado: (2023)

Altered Platelets’ morphological parameters in children with type 1 diabetes – a case-control study
por: Malachowska, Beata, et al.
Publicado: (2015)

Leucine-Rich Glioma Inactivated 1 Promotes Oligodendrocyte Differentiation and Myelination via TSC-mTOR Signaling
por: Xie, Ya-Jun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3hkh8qunecp3t4j8e6sb2fqbfv